{"text": "amlx vygr esaly wve reta biib despite regulatory progress delivery hurdles persist for neurodegenerative space biospace jobs"}
{"text": "anyone in the ad field who cannot see the data released yesterday by sava as promising not conclusive but very promising is nothing but a hater especially if they were just shouting on rooftops when biib released data on lecanemab it s that simple"}
{"text": "sava pfe biib lly better than any other alzheimers drug statistics and third party data does not lie its what the shorts asked for all along a third party and no wang and guess what shorts were wrong imagine soon higher doses help for patients and safety cassavasciences"}
{"text": "nbix krtx vygr biib nvs lly cns new report on neurocrine s 4q earnings expectations and impending february pipeline results for cah seizure and chorea via huntington s disease"}
{"text": "guess what guys analysts said this independent graph is uninterpretable clearly in mild to moderate sava simufilam spanks tf out of lly solanezumab and biib lecanemab and adunumab this is only phase 2b next up are 12 month cognitive maint study"}
{"text": "form sc 13g a statement of acquisition of beneficial ownership by individuals filed with the sec biib"}
